Advertisement

Archives of oto-rhino-laryngology

, Volume 239, Issue 1, pp 41–47 | Cite as

Changes in the stria vascularis of the guinea pig due to cis-platinum

  • R. A. Tange
  • V. D. Vuzevski
Article

Summary

The microscopical and ultramicroscopical changes in the stria vascularis due to cis-diamminedichloroplatinum II (DDP) were studied. Sixteen healthy adult guinea pigs were used for the experiment. A standard dosage DDP (1.5 mg/kg/d) was administered over a period of 5–20 days. A clear degeneration pattern was found (ranging from no changes to cystic degeneration with protrusion of marginal cells followed by loss of marginal cells). DDP seems to be especially toxic for marginal cells in stria vascularis in the guinea pig.

Key words

Cis-diamminedichloroplatinum II Guinea pig Stria vascularis Changes in marginal cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dixon RL, Cooney DA, Davis RD, Heyman JA, Fleischman RW, Schaeppi RW (1971) Preclinical toxicological studies of cis-dichlorodiammine platinum II. Proc International Congress Chemotherapy, Prague 1971. Vol. 2: 243–245Google Scholar
  2. 2.
    Merrin CE (1978) Efficacy of cisplatinum in genito-urinary tumors. Experience in 200 cases. Biochemie 60. No. 9: 941–947Google Scholar
  3. 3.
    Gralla RJ, Cvitkovic E, Colbey RB (1979) Cis-dichlorodiammine platinum II in non small cell carcinoma of the lung. Cancer Treat Rep 63: 1585–1588Google Scholar
  4. 4.
    Peppard SB, Saraff M, Powers WE, Loh IK, Weaver AW (1980) Combination of cis-platinum, oncovin and bleomycin (CoB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck. Laryngoscope 90: 1273–1280Google Scholar
  5. 5.
    Williams CJ, Whitehouse JMR (1979) Cis-platinum: a new anticancer agent. Br Med J 1: 1691–1698Google Scholar
  6. 6.
    Piel J, Meyer D, Perlia C, Wolfe V (1974) Effects of cis-diammine dichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep 58: 871–875Google Scholar
  7. 7.
    Kelson L, Okonkwo E, Anton L, Cvitkovic E (1978) Cis-platinum ototoxicity. Clin Toxicol 13: 469–478Google Scholar
  8. 8.
    Rybak LP (1981) Cis-platinum associated hearing loss. J Laryngol Otol 95: 745–747Google Scholar
  9. 9.
    Fleischmann RW, Stadnicki SW, Ethier MF, Schaeppi U (1975) Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig. Toxicol Appl Pharmacol 33: 320–332Google Scholar
  10. 10.
    Stadnicki SW, Fleischmann RW, Schaeppi U, Merriam P (1975) Cis-dichlorodiammine platinum II (NSC-119875). Hearing loss and other toxic effects in rhesus monkeys. Cancer Chemother Rep 59: 467–480Google Scholar
  11. 11.
    Komune S, Asakuma S, Snow JB (1981) Pathophysiology of the ototoxicity of cis-diammine dichloroplatinum. Otolaryngol Head Neck Surg 89: 275–282Google Scholar
  12. 12.
    Tange RA, Conijn EAJG, Van Zeijl LPGM (1982) The cortitoxic effect of cis-platinum in the guinea pig. Arch Otorhinolaryngol (NY) 237: 17–26Google Scholar
  13. 13.
    Nakai Y, Konishi K, Chang KC, Ohashi N, Morisaka N, Minowa Y, Morimoto A (1982) Ototoxicity of the anticancer drug cisplatinum. Acta Otolaryngol (Stockh) 93: 227–232Google Scholar
  14. 14.
    Tange RA, Conijn EAJG, Van Zeijl LPGM, Huzing EH (1982) Pattern of gentamicin-induced cochlear degeneration in the guinea pig. Arch Otorhinolaryngol (NY) 236: 173–184Google Scholar
  15. 15.
    Hawkins JE Jr, Johnsson LG (1975) Microdissection and surface preparations of the inner ear. In: Smith CA, Vernon JA (eds) Handbook of the auditory and vestibular research methods. Thomas, Springfield, Ill., pp 5–52Google Scholar
  16. 16.
    Tange RA, Huizing EH (1980) Hearing loss and inner ear changes in a patient with severe gentamicin ototoxicity. Arch Otorhinolaryngol (NY) 228: 113–121Google Scholar
  17. 17.
    Hawkins JE Jr, Johnson LG (1981) Histopathology of cochlear and vestibular ototoxicity in laboratory animals. In: Lerner SA, Matz GJ, Hawkins JE Jr (eds) Aminoglycoside ototoxicity. Little, Brown and Company, Boston, pp 175–195Google Scholar
  18. 18.
    Anniko M (1976) Surface structure of the stria vascularis in the guinea pig cochlea. Acta Otolaryngol (Stockh) 82: 343–353Google Scholar
  19. 19.
    Brummett R, Smith CA, Ueno Y, Cameron S, Richter R (1977) The delay effects of ethracrynic acid on the stria vascularis of the guinea pig. Acta Otolaryngol (Stockh) 83: 98Google Scholar
  20. 20.
    Bosher SK (1980) The nature of the ototoxic actions of ethacrynic upon the mammalia endolymphatic system (II). Acta Otolarnygol (Stockh) 90: 40–54Google Scholar
  21. 21.
    Arnold W, Nadol JB, Weidauer H (1981) Ultrastructural histopathology in a case of human ototoxicity due to loop diuretics. Acta Otolaryngol (Stockh) 91: 399–414Google Scholar
  22. 22.
    Bagger-Sjöback D, Filipek CS, Schacht J (1980) Characteristics and drug responses of cochlear and vestibular adenylate cyclase. Arch Otorhinolaryngol (NY) 228: 217–222Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • R. A. Tange
    • 1
  • V. D. Vuzevski
    • 2
  1. 1.Dept. of OtorhinolaryngologyUniversity Hospital “Dijkzigt”GD RotterdamThe Netherlands
  2. 2.Dept. of PathologyUniversity Hospital “Dijkzigt”GD RotterdamThe Netherlands

Personalised recommendations